Skip to main content

Red Skin Syndrome

  • 999 Accesses

Abstract

Red skin syndrome (RSS) is a condition that can develop after stopping long-term continuous use of topical steroids. In RSS, erythema or exudative erythema extends from the original location of the rash where topical steroids had been applied to sites where steroids were never used. The disorder may take weeks to several years to resolve and some patients experience repeated seasonal exacerbation long term.

Keywords

  • Topical steroid addiction (TSA)
  • Topical steroid withdrawal (TSW)
  • 11-Beta-HSD2

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-981-10-4609-4_16
  • Chapter length: 10 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-981-10-4609-4
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.99
Price excludes VAT (USA)
Hardcover Book
USD   149.99
Price excludes VAT (USA)
Fig. 16.1
Fig. 16.2
Fig. 16.3
Fig. 16.4
Fig. 16.5
Fig. 16.6

References

  1. Rapaport MJ, Rapaport V. The red skin syndromes: corticosteroid addiction and withdrawal. Expert Rev Dermatol. 2006;1(4):547–61.

    CAS  CrossRef  Google Scholar 

  2. Rapaport MJ. Red scrotum syndrome. Cutis. 1998;61(3):128B.

    CAS  PubMed  Google Scholar 

  3. Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol. 2003;21(3):201–14.

    CrossRef  PubMed  Google Scholar 

  4. Enomoto T, Arase S, Shigemi F, Takeda K. Steroid withdrawal syndrome by topical corticosteroid. J Jpn Cosm Sci Soc (Jpn). 1991;15(1):17–24.

    Google Scholar 

  5. Fukaya M. Color atlas of steroid withdrawal from topical corticosteroid in patients with atopic dermatitis. Tokyo: Ishiyaku Publishers; 2000.

    Google Scholar 

  6. Rapaport MJ, Rapaport VH. Serum nitric oxide levels in “red” patients: separating corticosteroid-addicted patients from those with chronic eczema. Arch Dermatol. 2004;140(8):1013–4.

    CrossRef  PubMed  Google Scholar 

  7. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. 2006;118(1):3–21.

    CAS  CrossRef  PubMed  Google Scholar 

  8. Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137:107–23.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  9. Fukaya M. Histological and immunohistological findings using anti-cortisol antibody in atopic dermatitis with topical steroid addiction. Dermatol Ther (Heidelb). 2016;6(1):39–46.

    CrossRef  Google Scholar 

  10. Fukaya M. Cortisol homeostasis in the epidermis is influenced by topical corticosteroids in patients with atopic dermatitis. Indian J Dermatol. 2017. (In press).

    Google Scholar 

  11. Tiganescu A, Walker EA, Hardy RS, Mayes AE, Stewart PM. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin. J Invest Dermatol. 2011;131(1):30–6.

    CAS  CrossRef  PubMed  Google Scholar 

  12. Fukaya M, Sato K, Yamada T, Sato M, Fujisawa S, Minaguchi S, et al. A prospective study of atopic dermatitis managed without topical corticosteroids for a 6-month period. Clin Cosmet Investig Dermatol. 2016;9:151–8.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  13. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5):e808–14.

    CrossRef  PubMed  Google Scholar 

  14. Agren J, Sjörs G, Sedin G. Ambient humidity influences the rate of skin barrier maturation in extremely preterm infants. J Pediatr. 2006;148(5):613–7.

    CrossRef  PubMed  Google Scholar 

  15. Takei K, Denda S, Kumamoto J, Denda M. Low environmental humidity induces synthesis and release of cortisol in an epidermal organotypic culture system. Exp Dermatol. 2013;22(10):662–4.

    CAS  CrossRef  PubMed  Google Scholar 

  16. Boix J, Sevilla LM, Sáez Z, Carceller E, Pérez P. Epidermal mineralocorticoid receptor plays beneficial and adverse effects in skin and mediates glucocorticoid responses. J Invest Dermatol. 2016;136(12):2417–26.

    CAS  CrossRef  PubMed  Google Scholar 

  17. Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818–23.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  18. Horimukai K, Morita K, Narita M, Kondo M, Kitazawa H, Nozaki M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):824–30.

    CrossRef  PubMed  Google Scholar 

  19. Skobowiat C, Dowdy JC, Sayre RM, Tuckey RC, Slominski A. Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab. 2011;301(3):E484–93.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  20. Teelucksingh S, Mackie AD, Burt D, McIntyre MA, Brett L, Edwards CR. Potentiation of hydrocortisone activity in skin by glycerrhetinic acid. Lancet. 1990;335(8697):1060–3.

    CAS  CrossRef  PubMed  Google Scholar 

  21. Barnes L, Ino F, Jaunin F, Saurat JH, Kaya G. Inhibition of putative hyalurosome platform in keratinocytes as a mechanism for corticosteroid-induced epidermal atrophy. J Invest Dermatol. 2013;133(4):1017–26.

    CAS  CrossRef  PubMed  Google Scholar 

  22. Hatano Y, Elias PM, Crumrine D, Feingold KR, Katagiri K, Fujiwara S. Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis. J Invest Dermatol. 2011;131(9):1845–52.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  23. Fukaya M, Kimata H. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study. J Drugs Dermatol. 2014;13(3):259–63.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mototsugu Fukaya .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Fukaya, M. (2018). Red Skin Syndrome. In: Lahiri, K. (eds) A Treatise on Topical Corticosteroids in Dermatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-4609-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4609-4_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4608-7

  • Online ISBN: 978-981-10-4609-4

  • eBook Packages: MedicineMedicine (R0)